Applied DNA Sciences Shares Surge 28.83% Ahead of Reverse Split

DNA Sciences shares surged 28.83% in pre-market trading today, marking a significant upward movement ahead of the regular session. The jump follows recent corporate actions aimed at stabilizing the company’s stock position.

Applied DNA Sciences announced a 1-for-15 reverse stock split set to take effect on June 2, 2025. This move reduces the outstanding shares from approximately 7.8 million to around 519,000, aligning the stock price with Nasdaq’s $1.00 minimum bid requirement. The adjustment will also proportionally revise equity instruments like options, warrants, and shares under incentive plans, without issuing fractional shares.

Analysts highlight the reverse split as a strategic response to regulatory compliance, potentially boosting the stock’s appeal to investors by raising its per-share price. The company emphasized no changes to its par value or Nasdaq listing status, with trading resuming under the same “APDN” ticker post-split. Market sentiment appears buoyed by the move, though long-term implications depend on the company’s ability to sustain value post-adjustment.